- cafead   Jul 26, 2023 at 09:52: AM
via MindBio Therapeutics has started enrolling patients in its Phase II trial evaluating microdoses of lysergic acid diethylamide (LSD) combined with meaning-centred psychotherapy in advanced-stage cancer patients experiencing emotional distress.
article source
article source